Also talks about the state of the company.
Despite MCI's attempts to get back on track, some analysts are still skeptical. Patrick Comack, an equities analyst with Guzman & Co., said the cards are stacked against MCI. ... "MCI is under the gun, with so many negative forces against it," Comack said. "They've still got a very rough road ahead of them. The only recourse I see is to sell the company."Well we'll see. Mergers (getting bough, whatever) has been good for our group in the past. But it is always a stressful time. Personally I hope it doesn't happen. Haven't heard anything, but we are usually the last to know.
No comments:
Post a Comment